These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16989913)

  • 1. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
    Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
    Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.
    Pein F; Sakiroglu O; Dahan M; Lebidois J; Merlet P; Shamsaldin A; Villain E; de Vathaire F; Sidi D; Hartmann O
    Br J Cancer; 2004 Jul; 91(1):37-44. PubMed ID: 15162142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk of symptomatic cardiac events in childhood cancer survivors.
    van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
    J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
    Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
    Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac morbidity of adjuvant radiotherapy for breast cancer.
    Patt DA; Goodwin JS; Kuo YF; Freeman JL; Zhang DD; Buchholz TA; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2005 Oct; 23(30):7475-82. PubMed ID: 16157933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac toxicity in cancer therapy].
    Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I
    Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view].
    Pein F; Iserin L; de Vathaire F; Lemerle J
    Bull Cancer; 2004 Nov; 91 Suppl 3():185-91. PubMed ID: 15899626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
    Johansen S; Danielsen T; Olsen DR
    Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
    Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality.
    Haddy N; Mousannif A; Tukenova M; Guibout C; Grill J; Dhermain F; Pacquement H; Oberlin O; El-Fayech C; Rubino C; Thomas-Teinturier C; Le-Deley MC; Hawkins M; Winter D; Chavaudra J; Diallo I; de Vathaire F
    Brain; 2011 May; 134(Pt 5):1362-72. PubMed ID: 21596770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
    Andolina JR; Dilley K
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late effects of thoracic irradiation in children.
    Bölling T; Könemann S; Ernst I; Willich N
    Strahlenther Onkol; 2008 Jun; 184(6):289-95. PubMed ID: 18535803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients.
    Doyle JJ; Neugut AI; Jacobson JS; Wang J; McBride R; Grann A; Grann VR; Hershman D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):82-93. PubMed ID: 17336464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal function testing in pediatric cancer survivors.
    Patterson BC; Truxillo L; Wasilewski-Masker K; Mertens AC; Meacham LR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1302-7. PubMed ID: 19637328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.
    Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T
    Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.